DaVita Inc (NYSE:DVA) - Share price


Stock Report

DaVita Inc DVA

Last Price
$92.92

Day Change
0.58|0.63%

As of 16/08/2022
19:00:00 EDT | USD
Minimum 15 Minutes Delay.

Last Close92.34
Day Range92.18 - 93.61
Mkt Cap8.48Bil
52-Wk Range74.97 - 133.88
Yield %-
ISINUS23918K1088
Volume679,642
P/E11.43
P/S0.83
P/CF5.97

Share Price

Financials
201920202021
More ...
Income Statement
Revenue11,388.4811,550.6011,618.80
Operating Income1,755.531,683.971,770.43
Net Income810.98773.64978.45
Basic EPS5.296.469.30
Avg. Diluted Shares Outstanding154123110
Balance Sheet
Current Assets3,690.173,148.723,167.72
Non Current Assets13,621.2213,839.7913,953.77
Total Assets17,311.3916,988.5217,121.49
Current Liabilities2,372.102,476.142,398.53
Total Liabilities---
Total Equity2,133.411,383.57755.51
Cash Flow
Operating Cash Flow2,072.361,979.031,930.88
Capital Expenditure-766.55-674.54-641.47
Free Cash Flow1,305.811,304.491,289.41

In millions, except "Basic EPS". Currency is USD.

Company Profile

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

Sector

Healthcare

Industry

Medical Care Facilities

Stock Style

Mid-Value

Fiscal Year Ends

December

Employees

69,000
Key Stats
More ...
Price/Earning TTM10.97
Price/Book13.94
Price/Sales TTM0.85
Rev Growth (3 year avg)0.62
EPS Growth (3 year avg)-
Operating Margin % TTM15.24
Net Margin % TTM8.42
ROE TTM91.48
Debt/Equity15.09
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2022 Morningstar. All rights reserved.